A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia-Reference-Cited by-同舟云学术

A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia

Published:2022-10 Issue:10 Volume:44 Page:1310-1325
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Jeong Han Saem,Hong Soon Jun,Cho Jin-Man,Han Ki Hoon,Cha Dong-Hun,Jo Sang-Ho,Kang Hyun-Jae,Choi So-Yeon,Choi Cheol Ung,Cho Eun Jeong,Jeong Young-Hoon,Gwon Hyeon-Cheol,Kim Byeong-Keuk,Lee Sung Yun,Kim Sang-Hyun,Ahn Jeong Cheon,Hong Young Joon,Kim Woo-Shik,Woo Seong-Ill,Park Tae-Ho,Han Kyoo-Rok

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials;Sattar;Lancet,2010

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;Circulation,2019

4. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

5. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation);Global and Regional Health Technology Assessment;2024-06-11

2. ApoB100 and Atherosclerosis: What’s New in the 21st Century?;Metabolites;2024-02-12

3. Statins—From Fungi to Pharmacy;International Journal of Molecular Sciences;2023-12-29

4. Position Paper of the Polish Expert Group on the Use of Pitavastatin in the Treatment of Lipid Disorders in Poland Endorsed by the Polish Lipid Association.;Archives of Medical Science;2023-11-26

5. Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?;Metabolites;2023-01-18